These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9931112)

  • 21. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
    Chauvin B; Richer C; Giudicelli JF
    Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
    Soltis EE
    J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats.
    Marchand EL; Der Sarkissian S; Hamet P; deBlois D
    Circ Res; 2003 Apr; 92(7):777-84. PubMed ID: 12623880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension.
    Yamada Y; Tsuboi K; Hattori T; Murase T; Ohtake M; Furukawa M; Ueyama J; Nishiyama A; Murohara T; Nagata K
    Hypertens Res; 2011 Jul; 34(7):809-16. PubMed ID: 21471973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels.
    Black MJ; Campbell JH; Campbell GR
    Am J Cardiol; 1993 Jun; 71(17):17E-21E. PubMed ID: 8328362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity.
    Tea BS; Dam TV; Moreau P; Hamet P; deBlois D
    Hypertension; 1999 Aug; 34(2):229-35. PubMed ID: 10454446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
    Cooper ME; Rumble JR; Allen TJ; O'Brien RC; Jerums G; Doyle AE
    Kidney Int; 1992 Apr; 41(4):898-903. PubMed ID: 1513111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
    Therrien F; Lemieux P; Bélanger S; Agharazii M; Lebel M; Larivière R
    Eur J Pharmacol; 2009 Apr; 607(1-3):126-34. PubMed ID: 19326569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1993 Nov; 22(5):682-7. PubMed ID: 8225528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy.
    Canby CA; Tomanek RJ
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1110-8. PubMed ID: 2529781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of indapamide and hydrochlorothiazide on cardiac hypertrophy and vascular smooth-muscle phenotype in the stroke-prone, spontaneously hypertensive rat.
    Contard F; Glukhova M; Sabri A; Marotte F; Sartore S; Narcisse G; Schatz C; Guez D; Rappaport L; Samuel JL
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S29-34. PubMed ID: 7508058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    Helle F; Iversen BM; Chatziantoniou C
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
    Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T
    Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effect of sesamin. III. Protection against development and maintenance of hypertension in stroke-prone spontaneously hypertensive rats.
    Matsumura Y; Kita S; Tanida Y; Taguchi Y; Morimoto S; Akimoto K; Tanaka T
    Biol Pharm Bull; 1998 May; 21(5):469-73. PubMed ID: 9635502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats.
    Kähönen M; Tolvanen JP; Kalliovalkama J; Wu X; Karjala K; Mäkynen H; Pörsti I
    Eur J Pharmacol; 1999 Mar; 368(2-3):213-22. PubMed ID: 10193657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
    Christensen KL; Jespersen LT; Mulvany MJ
    J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II.
    Devlin AM; Davidson AO; Gordon JF; Campbell AM; Morton JJ; Reid JL; Dominiczak AF
    J Hum Hypertens; 1995 Jun; 9(6):497-500. PubMed ID: 7473534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.